CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 88 enrolled
Drug / intervention
D5W +1 moredrug
Likely dose
Thiamine 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01070810
NCT01070810Phase 2Completed
CompareCT.gov

Thiamine as a Metabolic Resuscitator in Septic Shock

Beth Israel Deaconess Medical Center·interventional·Posted Feb 18, 2010·Updated May 15, 2017

In Brief

A Phase 2 clinical trial evaluating D5W and Thiamine for Septic Shock. Completed, enrolled 88 participants across 1 site.

Detailed Summary

The major goal of this project is to determine whether the use of thiamine in patients with septic shock will result in attenuation of lactic acidosis and a more rapid reversal of shock.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH)

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 18, 2010
Enrollment StartFeb 1, 2010
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 16.4 years ago

Interventions

D5Wdrug

Dextrose 5%

Thiaminedrug

Thiamine 200mg in 50ml D5W